Strides Pharma’s arm to acquire 80% stake in Pharmapar

29 Jan 2019 Evaluate

Strides Pharma Science’s step down subsidiary Strides Pharma Canada Inc., Canada has entered into an arrangement to acquire 80% stake in Pharmapar Inc., a Canada based specialised generics front end company.

Foray in Canada which is a new market for the company and one of top 10 global pharmaceutical markets. As per IQVIA, the market is estimated at $21 billion with a significant share of generics through retail pharmacies. The company to fast track growth in the region through rapid portfolio expansion driven by its fungible portfolio built in the markets of US, Europe and Australia.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.


Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×